This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Abbvie Biotechnology Ltd. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Michael Neu - Innovator in Pharmaceutical Formulations
Introduction
Michael Neu is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical formulations. His work focuses on improving the efficacy and comfort of treatments for patients.
Latest Patents
Michael Neu holds a patent for "High concentration anti-TNFα antibody liquid formulations." This invention provides a liquid aqueous pharmaceutical formulation comprising a human anti-TNFα antibody, or an antigen-binding portion thereof. The formulation is designed to reduce pain associated with injection in a subject by at least about 50% when compared to injecting an otherwise identical formulation comprising at least one salt and/or at least one buffer. Additionally, it offers increased bioavailability upon subcutaneous administration into a subject.
Career Highlights
Michael Neu is currently associated with AbbVie Biotechnology Ltd., where he continues to innovate in the field of pharmaceutical formulations. His work has the potential to significantly enhance patient experiences and treatment outcomes.
Collaborations
Some of his notable coworkers include Markus Tschoepe and Carsten Weber, who collaborate with him on various projects within the biotechnology sector.
Conclusion
Michael Neu's contributions to pharmaceutical formulations exemplify the importance of innovation in improving patient care. His patent reflects a commitment to enhancing the effectiveness and comfort of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile